Cite
HARVARD Citation
Hong, D. et al. (n.d.). 285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors. Journal for immunotherapy of cancer. p. A174. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hong, D. et al. (n.d.). 285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors. Journal for immunotherapy of cancer. p. A174. [Online].